Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Southwest Research Institute (SwRI) is an independent nonprofit contract research organization providing multidisciplinary R&D services—including pharmaceutical development and biologics manufacturing—to government and industry clients worldwide. It offers CGMP facilities for small molecule synthesis, biologics production (including cell/gene therapies), vaccine manufacture, medical device prototyping/testing, analytical method development, regulatory support services, tissue engineering expertise, and more. The institute does not develop its own pipeline of therapeutics but enables sponsors’ drug/device candidates to progress from concept through preclinical studies into early-phase clinical trials by supplying process development expertise and GMP materials. Recent expansions include a new Clinical Supply Facility supporting stem cells/vaccines/small molecules for trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Southwest Research Institute.